This review critically analyzes current gaps in knowledge, including long-term biocompatibility, degradation pathways, immune interactions, and structure–activity relationships, which currently limit clinical translation and positions MXenes as chemistry-programmable nanoplatforms with strong potential to bridge on-bod...
Damla Alkaya, Roberta Cagliani, Gokce Yagmur Summak et al.· ACS Nano· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.